Personal profile


Apolipoprotein A-I in HDL

Apolipoprotein A-I is the major protein of high-density lipoprotein (HDL) in the transportation of cholesterol and other lipids in vivo. Rare variants of apoA-I aggregate as amyloids, leading to organ dysfunction. The structure-function relationship of atheroprotective and amyloidogenic apoA-I variants are investigated.

HDL also correlates to improved glucose metabolism in the diabetic state. Learning more about HDL, will lead in the search for new innovative peptide drugs to prevent and treat diabetes and atherosclerosis.


Zinc transporter ZnT8 in diabetes

The ZnT8 transporter is localized to insulin granules in pancreatic beta cells were microcrystals of insulin-zinc are stored. ZnT8 polymorphism relates to type 1 and type 2 diabetes, and constitutes a potential target for prevention and treatment. Analyses of variant-specific protein structure and function, and cellular organization and functionality, are carried out to understand the role of ZnT8 in diabetes. 

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

UKÄ subject classification

  • Medical and Health Sciences
  • Cell and Molecular Biology
  • Endocrinology and Diabetes
  • Biochemistry and Molecular Biology
  • Structural Biology

Free keywords

  • Protein Structure
  • Diabetes
  • Cardiometabolic disease
  • Amyloid


Dive into the research topics where Jens Lagerstedt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or